ANIFROLUMAB for Dermatomyositis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where ANIFROLUMAB was used for Dermatomyositis.
Most Reported Side Effects for ANIFROLUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 33 | 8.9% | 1 | 8 |
| Systemic lupus erythematosus | 31 | 8.4% | 1 | 7 |
| Drug ineffective | 26 | 7.0% | 0 | 5 |
| Fatigue | 19 | 5.1% | 0 | 3 |
| Arthralgia | 18 | 4.9% | 0 | 2 |
| Pyrexia | 18 | 4.9% | 0 | 9 |
| Covid-19 | 17 | 4.6% | 0 | 6 |
| Cough | 16 | 4.3% | 0 | 5 |
| Headache | 16 | 4.3% | 0 | 4 |
| Lupus nephritis | 16 | 4.3% | 0 | 1 |
| Nausea | 16 | 4.3% | 0 | 5 |
| Pain | 16 | 4.3% | 0 | 5 |
| Treatment failure | 15 | 4.0% | 0 | 0 |
| Herpes zoster | 14 | 3.8% | 1 | 2 |
| Inappropriate schedule of product administration | 14 | 3.8% | 0 | 4 |
Other Indications for ANIFROLUMAB
Systemic lupus erythematosus (250)
Autoantibody positive (41)
Chronic cutaneous lupus erythematosus (13)
Lupus nephritis (11)
Product used for unknown indication (5)
Other Drugs Used for Dermatomyositis
RITUXIMAB (993)
METHOTREXATE (958)
HUMAN IMMUNOGLOBULIN G (913)
PREDNISONE (744)
PREDNISOLONE (652)
METHYLPREDNISOLONE (647)
MYCOPHENOLATE MOFETIL (636)
TACROLIMUS (626)
CYCLOPHOSPHAMIDE (511)
HYDROXYCHLOROQUINE (419)